home
회사소개
home
회사개요
팀 키앤스톤 / 채용
시장 포지셔닝
주요사업
home

R&D

New Ingredient & Solution Co-Development

2025년 3Q
2
2025년 4Q
1
2026년 1Q
2
2026년 2Q
2
2026년 3Q
2
Setup
KEYNSTONE
Co-Development
Andalou
CRC
Aborlife
Co-Development
Andalou
CRC
Aborlife
Co-Development
Andalou
CRC
Aborlife
Lipolytic (DCA) & Anti-inflammatory (Bee Venom) Product R&D
Lifeceutical
Co-Development
Andalou
CRC
Aborlife
Lipolytic (DCA) & Anti-inflammatory (Bee Venom) Product R&D
Lifeceutical
Co-Development
Andalou
CRC
Aborlife
Lipolytic (DCA) & Anti-inflammatory (Bee Venom) Product R&D
Lifeceutical

NPD & Exclusive Distribution

Clinical Trials, MD Approval & Worldwide Launching

2025년 3Q
4
2025년 4Q
4
2026년 1Q
4
2026년 2Q
4
2026년 3Q
4
Clinical Partnership Agreement
Kyungpook National Univ.
IIT for MD cream
GMP Production Site Contract
C2
MD Approval
Licensing Contracting
Universal Studio
Licensed Character Product
Exclusive Distribution
IRB-approved Clinical Trial
IIT for MD cream
Prototype Production & Medical Device Approval Process
MD Approval
Product Development
Licensed Character Product
Exclusive Distribution
IRB-approved Clinical Trial
IIT for MD cream
Prototype Production & Medical Device Approval Process
MD Approval
Product Development
Licensed Character Product
Exclusive Distribution
Clinical Results Report
IIT for MD cream
Prototype Production & Medical Device Approval Process
MD Approval
Production in Korea
Licensed Character Product
Exclusive Distribution
Major Medical Conference Presentation
IIT for MD cream
Production & Launch
MD Approval
Worldwide Launching
Licensed Character Product
Exclusive Distribution

Lancet-Validated Hair Loss Solution